Israel’s coronavirus deaths jump to 33, after 7 succumb in a single day
Israel’s coronavirus death toll rose to 33 on Thursday afternoon as patients in Ashkelon and Tel Aviv succumbed to COVID-19, sustaining an increase in the fatality rate over the last several days.Israeli scientists: Coronavirus vaccine to be tested on humans by June 1
The deaths were the sixth and seventh announced on Thursday, bringing the toll over just the last day and a half to 13.
Barzilai Medical Center said one fatality was a 77-year-old man who suffered from several preexisting medical conditions.
The medical center said the man, whose name has not yet been released, had been brought to the hospital on March 22.
“His condition deteriorated and he was transferred a few days ago to the intensive care unit. In the past two days, his situation got much worse, and despite treatments with all possible equipment, the patient passed away,” the hospital said.
Medical personnel after evacuating a suspected COVID-19 patient at Shaare Zedek hospital in Jerusalem, March 31, 2020. (Nati Shohat/Flash90)
A second man, 90, died of the virus at Tel Aviv’s Ichilov Hospital, the medical center said. It said the victim had preexisting conditions.
All of Thursday’s victims have been men over 72 years old, and five of them had underlying conditions, according to hospitals announcing their deaths.
The death toll has more than doubled from 16 since Monday, and the number of people on ventilators or in serious condition has also nearly doubled in the last week.
A team of Israeli researchers says that they are days away from completing the production of the active component of a coronavirus vaccine that could be tested on humans as early as June 1.Corona Victims in Israel Had Pre-Existing Conditions
“We are in the final stages and within a few days we will hold the proteins – the active component of the vaccine,” Dr. Chen Katz, group leader of MIGAL’s biotechnology group, told The Jerusalem Post.
In late February, MIGAL [The Galilee Research Institute] committed to completing production of its vaccine within three weeks and having it on the market in 90 days. Katz said they were slightly delayed because it took longer than expected to receive the genetic construct that they ordered from China due to the airways being closed and it having to be rerouted.
As a reminder, for the past four years, researchers at MIGAL scientists have been developing a vaccine against infectious bronchitis virus (IBV), which causes a bronchial disease affecting poultry. The effectiveness of the vaccine has been proven in preclinical trials carried out at the Veterinary Institute.
“Our basic concept was to develop the technology and not specifically a vaccine for this kind or that kind of virus,” said Katz. “The scientific framework for the vaccine is based on a new protein expression vector, which forms and secretes a chimeric soluble protein that delivers the viral antigen into mucosal tissues by self-activated endocytosis, causing the body to form antibodies against the virus.”
At the Wolfson Medical Center in Holon, a 67-year-old patient who had been in an induced coma and on a ventilator for two weeks was taken off the ventilator on Tuesday night and is breathing on her own. Her condition has been upgraded to moderate. The patients contracted the virus while visiting Egypt with her partner.
The director of the corona ICU at Wolfson called the woman's case "encouraging."
"Of course, we are continuing to monitor the patient's condition closely, and hope that we will soon be able to report more improvement," he noted.
Israel Hayom has elected to take a closer look at the "pre-existing conditions" that have been reported for all the corona fatalities in the country thus far and discovered that while the term might imply that the victims were already critically ill, in at least some cases the "pre-existing conditions" were common medical conditions that in approximately one-third of the Israeli population over 40 have: diabetes, heart disease, and high blood pressure.
Israel Hayom identified the "pre-existing conditions" from which 18 of the 21 victims suffered and discovered that eight were diabetics; eight had high blood pressure; and seven suffered from heart and vascular disease. Five of the patients were in varying states of dementia or had suffered strokes or a loss of cognitive functioning. Another four had respiratory illnesses. One patient who succumbed to coronavirus already had liver disease, an autoimmune condition, and cancer.